High-content screen in human pluripotent cells identifies miRNA-regulated pathways controlling pluripotency and differentiation by De Souza Lima, I. M. et al.
RESEARCH Open Access
High-content screen in human pluripotent
cells identifies miRNA-regulated pathways
controlling pluripotency and differentiation
Ildercílio Mota de Souza Lima1,2, Josiane Lilian dos Santos Schiavinato1,2, Sarah Blima Paulino Leite1,2,
Danuta Sastre1, Hudson Lenormando de Oliveira Bezerra1,2, Bruno Sangiorgi1,2, Amanda Cristina Corveloni1,2,
Carolina Hassibe Thomé5, Vitor Marcel Faça5, Dimas Tadeu Covas1,2, Marco Antônio Zago1,2, Mauro Giacca3,
Miguel Mano3,4 and Rodrigo Alexandre Panepucci1,2*
Abstract
Background: By post-transcriptionally regulating multiple target transcripts, microRNAs (miRNAs or miR) play
important biological functions. H1 embryonic stem cells (hESCs) and NTera-2 embryonal carcinoma cells (ECCs) are
two of the most widely used human pluripotent model cell lines, sharing several characteristics, including the
expression of miRNAs associated to the pluripotent state or with differentiation. However, how each of these
miRNAs functionally impacts the biological properties of these cells has not been systematically evaluated.
Methods: We investigated the effects of 31 miRNAs on NTera-2 and H1 hESCs, by transfecting miRNA mimics.
Following 3–4 days of culture, cells were stained for the pluripotency marker OCT4 and the G2 cell-cycle marker
Cyclin B1, and nuclei and cytoplasm were co-stained with Hoechst and Cell Mask Blue, respectively. By using
automated quantitative fluorescence microscopy (i.e., high-content screening (HCS)), we obtained several
morphological and marker intensity measurements, in both cell compartments, allowing the generation of a
multiparametric miR-induced phenotypic profile describing changes related to proliferation, cell cycle, pluripotency,
and differentiation.
Results: Despite the overall similarities between both cell types, some miRNAs elicited cell-specific effects, while
some related miRNAs induced contrasting effects in the same cell. By identifying transcripts predicted to be
commonly targeted by miRNAs inducing similar effects (profiles grouped by hierarchical clustering), we were able
to uncover potentially modulated signaling pathways and biological processes, likely mediating the effects of the
microRNAs on the distinct groups identified. Specifically, we show that miR-363 contributes to pluripotency
maintenance, at least in part, by targeting NOTCH1 and PSEN1 and inhibiting Notch-induced differentiation, a
mechanism that could be implicated in naïve and primed pluripotent states.
Conclusions: We present the first multiparametric high-content microRNA functional screening in human pluripotent
cells. Integration of this type of data with similar data obtained from siRNA screenings (using the same HCS assay)
could provide a large-scale functional approach to identify and validate microRNA-mediated regulatory mechanisms
controlling pluripotency and differentiation.
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Background
A great effort has been devoted to the study of self-
renew and pluripotency of embryonic stem cells (ESCs)
[1], given their enormous potential in regenerative medi-
cine. A set of core transcription factors (TFs), including
OCT4, SOX2, KLF4, and c-MYC (OSKM), sustains plur-
ipotency in ESCs [2, 3] and can reprogram somatic cells
into induced pluripotent stem cells (iPSCs) [4, 5].
Distinct from TFs, microRNAs (miRs) are small (~ 22 nt)
RNA molecules that act as major post-transcriptional
regulators, by binding to partially complementary target
mRNAs, blocking their translation and/or leading to their
degradation [6]. Despite their small number (2,654 mature
miRs, miRBase release 22), they regulate a large fraction of
the transcriptome. Their biogenesis involves their tran-
scription as primary miRs (pri-miRs), which assume
secondary self-complementary hairpin structures, that are
processed in the nucleus by the DROSHA/DGCR8 micro-
processor complex giving rise to precursor hairpin miRs
(pre-miRs) [7]. These pre-miRs are exported to the
cytoplasm and further processed by Dicer to generate the
mature miR duplex, composed by one 5′ and 3′ strands
(-5p and -3p suffixes in miR names, respectively). This du-
plex is loaded into the RNA-induced silencing complex
(RISC), which contains an Argonaute (AGO) protein, and
the passenger strand is removed and degraded (historically
referred as star “*” strand), while the guide strand drives
the complex to the target mRNAs, inhibiting their transla-
tion and/or destabilizing and reducing their transcript
levels [6, 8].
Transcriptomic studies have identified miRs specific-
ally expressed in pluripotent cells, and repressed upon
differentiation, that could be involved in the mainten-
ance of their undifferentiated properties, as well as miRs
with opposite roles, induced upon differentiation [9, 10].
For instance, Stadler et al. found that many miRs mem-
bers of the miR-302 and miR-371–373 clusters and of
the miR-17 family were highly expressed in pluripotent
cells and downregulated in most cell lines during differ-
entiation (including hESCs and NT2 cells); conversely,
several miRs allocated in specific chromosomal clusters
(such as miR-24/miR-27a/miR-23a) were induced during
differentiation [10]. Interestingly, pluripotency-related
miRs can improve iPSC reprogramming induced by TFs
or even completely substitute them [11–15].
Despite the advances in functional genomics, with
genome-wide methods able to profile the transcriptome,
proteome, and miRNome of pluripotent cells, a true
understanding of how these gene products impact cell
biology depends on experimental approaches able to sys-
tematically identify and quantify molecular and pheno-
typic events affected by gain or loss-of-function. In this
context, high-content screening (HCS) combines the
automated acquisition of fluorescence microscopy images
of cell-based assays (carried in multiwell plates) with
quantitative digital image processing, allowing the simul-
taneous study of multiple characteristics in stem cells [16].
Specifically, by coupling immunofluorescence of selected
markers to nuclear and cytoplasmic fluorescent stains,
several morphometric and intensity measurements can be
simultaneously quantified at the single-cell level [17, 18],
allowing the functional dissection of phenotypic conse-
quences of miR [19]. Up to date, only three small focused
screenings have evaluated miR roles in pluripotency, all
using a mouse ESC line knockout for DGCR8 [18]. This
cell line lacks most endogenous miRs [20–22] and was
initially generated to assess the role of DGCR8 in miR
processing and to study the global role of miRs in early
embryonic development and ES cell differentiation. Al-
though mESCs from Dgcr8−/− embryos are morphologic-
ally normal and express ESC-specific markers, they show
an extended population doubling time with accumulation
in the G1 cell cycle phase and show large differentiation
defects, failing to repress pluripotency markers [23]. How
results from these screenings translate to cells containing
Dgcr8, and human cells, remains to be shown.
With this in mind, our aim was to identify microRNAs
and their predicted targeted pathways or processes, con-
tributing to pluripotency or differentiation of human
pluripotent cells. To this end, we developed a cell-based
assay to investigate, by HCS, the functional effects of 31
miRs differentially expressed between pluripotent and
differentiating cells [10, 24], using two of the most stud-
ied human pluripotent cell lines in the literature, namely
NTera-2 (NT2) embryonal carcinoma (EC) cells, a clas-
sical model to study pluripotency [25, 26], and the H1
cell line, the first derived hESCs [1]. These cells share
several characteristics, including the expression of
pluripotency markers (e.g., OCT4, Nanog) [27–29], miR
expression profiles [30], and similar responses upon
differentiation induced by all-trans retinoic acid (atRA),
including changes in miR expression profile [10], mor-
phology, and expression of pluripotency markers [31].
Importantly, NT2 cells also closely resemble H1 hESCs
in terms of cell cycle control [32]. Human and mouse
ESCs are characterized by a high proliferation rate and a
shortened G1 phase, limiting the differentiation associ-
ated with this phase [32–34]. Importantly, the Cdk1-
Cyclin B complex seems the only complex with a cell
cycle-dependent behavior in mESCs [35] and, in contrast
to other cyclins (A, D, or E), Cyclin B1 (CCNB1) is the
only cyclin required until implantation of the embryo
[36]. Cyclin B levels increase during late-S across G2
and M phases and drastically drop upon re-entry into
G1, when it abruptly translocates into the nucleus
(shortly before nuclear envelope breakdown), being
degraded during G1 [37]. Components of the Cyclin B1
pathway are centrally involved in the dissolution of the
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pluripotent state, strongly connecting G2 phase with
pluripotency [38].
With that in mind, in addition to Oct4 and several
morphometrical parameters, we evaluated Cyclin B1 as a
surrogate marker of the undifferentiated status associ-
ated with the G2 phase of the cell cycle in pluripotent
cells. By clustering miRs based on the induced multi-
parametric phenotypic profiles, and by applying enrich-
ment analysis to the sets of predicted targets shared by
clusters of miRs inducing similar phenotypes, we were
able to uncover signaling pathways and biological pro-
cesses potentially mediating their effects on pluripotency
and differentiation. Specifically, we show evidence that
miR-363-3p decreases the transcript levels of its predicted
targets, the receptor NOTCH1 and PSEN1 (a Y-secretase
component mediating Notch activation), counteracting
the differentiation induced by the Notch ligand DLL1.
Methods
Study design (HCS assay and screening)
Detailed supplemental procedures can be found in an
additional file (see Additional file 1). Given the lack of
systematic studies evaluating the function of miRs in hu-
man pluripotent cells, we choose to functionally evaluate
a selected set of 31 miRs previously shown to be
differentially expressed between undifferentiated and
differentiating pluripotent human cells (see Additional file 2:
Table S1). These miRs were found to be induced (11 miRs)
or repressed in nine hESC lines (including H1 and H9) and
NT2 cells, upon transference from a condition favoring
their undifferentiated state to a condition promoting a
rapid shift toward multilineage differentiation [10]; most
miRs were initially cloned and characterized in mESCs [39]
and/or hESCs [40]. Additionally, part of the selected
pluripotency-related miRs were expressed at higher levels
in mESCs and miPSCs (as compared to mouse embryonic
fibroblasts-MEFs), had promoters associated with Oct4/
Sox2/Nanog/Tcf3, and also were actively transcribed dur-
ing miPSC reprogramming [24].
To extend the relevance of this screening, we used two
classical human pluripotent cell lines, NT2 EC cells
[25, 26] and H1 hESCs [1], which share several features,
including the expression of pluripotency markers (e.g.,
OCT4, Nanog) [27–29], and cell cycle characteristics, with
a shortened G1 phase [32], associated with the accumula-
tion of cells in G2 phase expressing high levels of cyclin
B1 [35, 37], which directly links cell cycle and pluripo-
tency [38].
Based on the above, we designed a cell-based assay,
compatible with HCS, to simultaneously evaluate mor-
phological and molecular changes related to pluripo-
tency, cell cycle status, and differentiation (Fig. 1, top
left panel). Cells were immunostained for OCT4 and
Cyclin B1 and counterstained with nuclear (Hoechst)
and cytoplasm (HCS CellMask Blue) fluorescent dyes.
This allowed the quantitative measurement of several
morphometrical as well as intensity features of the
markers OCT4 and Cyclin B1 at the single-cell level, in
the nuclei and cytoplasm compartments; stainings were
optimized so that segmentation of the nucleus and cyto-
plasm could both be performed in the blue channel, re-
spectively as high and medium fluorescence intensity
objects. We used this assay to carry two functional miR
screens, using H1 hESCs and NT2 EC cells (Fig. 1, top
right panel). For each screening, two 96-well plates were
used to accommodate triplicates of the 31 miR mimics
evaluated plus negative controls (miR-Ctr, a miR without
targets in the human transcriptome) and positive con-
trols for differentiation (atRA and esiRNA-OCT4), as
well as a lethal siRNA (siRNA-UBC, targeting the
essential gene UbiquitinC) to control for transfection ef-
ficiency. Following reverse transfection and culture for
3–4 days, automated image acquisition (9 sites per
well, × 10 objective) was performed using an ImageXpress
micro XLS HCS system (Molecular Devices) and image
and data analysis was performed using CellProfiler and
KNIME open-source softwares.
Transfection efficiency was evaluated by comparing the
total number of cells (nucleus counts) in wells with cells
transfected with a lethal siRNA-UBC control, to those
transfected with control miR-Ctr. To further evaluate if
both plates of each screening were comparable, for each
plate, we evaluated the reduction of nuclear OCT4 stain-
ing (as compared to cells transfected with miR-Ctr) in the
wells with cells transfected with esiRNA against OCT4 or
treated with 10 μM atRA.
Concentration of staining reagents (dyes or antibodies)
was defined following titration, in order to guarantee a
non-limiting excess of reagents, i.e., the reagent concen-
tration tested, in which there is no quantifiable increase
in staining intensity, as compared to the lower concen-
tration tested. Of notice, automation of image acquisi-
tion and analysis with the exact same parameters, an
inherent characteristic of the HCS approach, guaranties
an unbiased and reproducible quantitation, thus allowing
the results obtained from distinct wells to be compared
[41, 42]. In addition, in order to further validate the
quantitative results obtained by the antibodies used in
our HCS assay, we compared them to those obtained
with distinct antibodies (a total of three anti-OCT4 and
two anti-cyclin B1 antibodies). Moreover, western
blotting was used to further validate the specificity of se-
lected antibodies and, also, to compare how the quanti-
tative results obtained by HCS relate to those obtained
by densitometric analysis of western blot protein bands.
A detailed description can be found in the “Antibody
validation” section of the supplemental procedures
(Additional file 1).
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Image and data analysis
Image and data analysis was carried out using the soft-
wares CellProfiler (cellprofiler.org) [43, 44] and KNIME
(knime.com) [45]. Once segmented, several morphome-
trical features, as well as intensity-related measurements,
were obtained from the nucleus and cytoplasm of each
cell. Moreover, in order to minimize experimental plate-
to-plate variation, we carried a normalization using the
miR-Ctr wells (present in both plates) as references. The
resulting normalized values are represented as percent-
age of control (POC), allowing a direct comparison of all
treatment conditions in both plates of each screening
[45]. Median values from each quantified parameter
were combined in a multiparametric phenotypic profile
representing the effect of each miR in the whole popula-
tion. Details are provided in the supplemental experi-
mental procedures (see Additional file 1).
Phenotypic clustering of miRs, identification of shared
predicted targets, and pathway analysis
In order to obtain a less redundant and more naturally
interpretable set of biologically relevant phenotypic pa-
rameters, the following features were selected to com-
pose multiparametric phenotypic profiles: cell count,
solidity (a feature varying from 0, for complex shapes
with reentrances, up to 1, for solid shapes), eccentricity
(varying from 0 to 1, from round to increasingly ellip-
tical shapes), nuclear and cellular areas, nuclear and
Fig. 1 General outline of the study. First: A high-content screening (HCS) assay based on H1 hESCs and NTera-2 cells was developed, to explore
pluripotency and differentiation. Several morphometrical features, as well as intensity-related measurements (from OCT4 and Cyclin B1 staining),
were obtained from nuclei and cytoplasm compartments. Second: The HCS assay was used in a miR functional screen in 96-well plates to
investigate the effects of 31 miRs. Following transfection and culture, images were acquired with an ImageXpress micro XLS HCS system (Molecular
Devices). Third: Following image and data analysis (with CellProfiler and KNIME softwares, respectively), the multiparametric phenotypic profile
describing the functional effect of each miR was submitted to hierarchical clustering (using Cluster 3.0 and Java Treeview), allowing the identification
of miRs with similar functional effects (pro-pluripotency or pro-differentiation). Fourth: TargetScan was used to identify predicted targets shared by
miRs in the same cluster (i.e., inducing similar phenotypes). Signaling pathways and biological processes enriched for these shared targets were
identified using the DAVID tool
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cellular perimeter, and nuclear and cytoplasmic OCT4
and CCNB1fluorescence intensities. The phenotypic pro-
files obtained for all miR treatments were submitted to
hierarchical clustering using the software Cluster 3.0,
using centered correlation metrics and average linkage
[46], and heatmaps and clusters were generated and
visualized using Java Treeview [47]. Next, we used all
predicted mRNA targets of each miR, downloaded from
TargetScan Human 7.1 [48], to identify and select tran-
scripts commonly targeted by miRs belonging to the
same cluster. Finally, we used the DAVID (V6.8) [49, 50]
to identify enriched signaling pathways and biological
processes. Details are provided in the supplemental ex-
perimental procedures (see Additional file 1).
Evaluation of miR effects on transcript levels of predicted
target
NT2 cells were reverse transfected with selected mimics
in 12-well plates and cultured for 2 days prior to RNA ex-
traction. Total RNA was reverse transcribed using High
Capacity cDNA Reverse Transcription Kit, and qPCR was
performed using either TaqMan Universal PCR Master
Mix or Power SYBR Green PCR Master Mix. Relative
gene expression was obtained using the 2^-DDCT method
[51] (see Additional file 1, detailed supplemental experi-
mental procedures). TaqMan probes and SYBR Green
PCR primers used are listed in Table S2 and Table S3, re-
spectively (see Additional file 2).
Regulation of Notch pathway by microRNAs in
pluripotent stem cells
To further dissect the potential repression of Notch sig-
naling by miRs promoting pluripotency features, we ob-
tained a list of genes related to the Notch pathway and
identified all miRs targeting them. Four selected miRs
with more than ten targets (miR-302c-3p, miR-101-3p,
miR-363-3p, and miR-92a-3p) and two miRs with less
than five targets (miR-222-3p and miR-371-3p) were in-
dividually transfected NT2 cells in 96-well plates and
posteriorly co-cultured with OP9-ctrl or OP9-DL1 cells.
Cells were fixed and stained for OCT4, nucleus, and
cytoplasm and imaged as described before. The nuclear
OCT4 intensity was measured using CellProfiler, and the
results were compared to the cells transfected with pre-
miR negative control and co-cultured with OP9-Ctr.
Details are provided in the supplemental experimental
procedures (see Additional file 1).
Statistical analysis
GraphPad Prism 6.0 software (La Jolla, CA, USA) was
used for the statistical analysis. All experiments were
performed in triplicates. For qPCR data, we used a one-
tailed non-parametric Mann-Whitney test. For HCS
experiments, we used a non-parametric Kruskal-Wallis
test followed with Dunn’s multiple comparison test.
Results
Screening quality controls
Transfection efficiency was similarly high in both
screening plates for both cell lines (transfection effi-
ciency > 85%), as indicated by the marked reduction in
the total number of cells in wells transfected with the lethal
siRNA-UBC control, as compared to those transfected
with negative miR-Ctr molecules (see Additional file 3:
Figures S1 and S2). Additionally, we also evaluated the re-
duction in OCT4 nuclear intensity following transfection
with an esiRNA against OCT4 (as compared to controls
wells), allowing us to address the quantitative inter-plate
reproducibility of our experimental setting (a sum of trans-
fection efficiency, anti-OCT4 staining, image segmentation,
and quantitation of the resulting fluorescence intensity).
The reduction in OCT4 nuclear intensity upon transfec-
tion with esiRNA-OCT4 (or upon atRA-induced differenti-
ation), as compared to cells transfected with miR-Ctr, was
also comparable between both plates in the two screenings
(see Additional file 3: Figures S1 and S2). In order to
further validate the quantitative results obtained by the
antibodies used in our HCS assay, we compared them to
those obtained with distinct antibodies using quantitative
microscopy. As compared to untreated cells, the relative
reduction in the levels of OCT4 and cyclin B1 upon atRA
treatment (as quantified by HCS) was strikingly similar for
all antibodies used, ranging from 14 to 16%, respectively
(see Additional file 3: Figure S3A). Densitometric analysis
of western blots carried with proteins extracted from cells
cultured in parallel, under the same experimental condi-
tions, was much larger, with a 31–34% reduction in OCT4
levels and 50–53% reduction in cyclin B1 levels (see
Additional file 3: Figure S3B). Altogether, these results val-
idate the quantitative results obtained by the antibodies
used in our HCS assay and allowed us to confidently
proceed with the analysis of the screening results.
Phenotypic screening in NT2 and H1 cells
For both cell lines, for each miR and each parameter
quantified, we obtained 27 values derived from 9 images
acquired in each of the 3 replica wells. The median value
for OCT4 nuclear median intensity was used to generate
Fig. 2a. The primary results quantified for all 27 sites (and
all miRs) in NT2 and H1 cells can be seen (respectively)
in (Additional file 3: Figure S4A and B), allowing the vari-
ability of our HCS assay to be visually accessed. Overall,
both cell lines showed similar responses to the evaluated
miRs. In general, miRs enriched in pluripotent cells, and
whose expression was reportedly downregulated upon
differentiation of H1 and/or NT2 cells [10], had a pro-
pluripotency effect in our experimental setting, increasing
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nuclear and cytoplasmic OCT4 and CCNB1 levels. On the
other hand, miRs reported as upregulated upon differenti-
ation of H1 and/or NT2 cells [10] had the opposite effect
(Fig. 2a). For information on the evaluated miR, re-
garding their families and the clusters they belong,
see (Additional file 2: Table S1) and Fig. 2b.
Following hierarchical clustering of the multipara-
metric profiles, miRs eliciting similar phenotypic effects
were grouped together (for details, see bottom right
panel of Fig. 1 and supplemental experimental proce-
dures in Additional file 1). Importantly, median intensity
levels of OCT4 and CCNB1 in the nucleus and
Fig. 2 Effects of miRNAs on nuclear OCT4 levels in H1 hESCs and NT2 cells. a H1 hESCs and NT2 cells were transfected with miR mimics and the
negative control miR-Ctr (PMC) and then submitted to quantitative fluorescence microscopy. OCT4 nuclear median intensity is represented as a
percentage relative to the value observed in cells transfected with PMC (NT2 cell depicted as triangles and H1 hESCs as circles). Colored bars in
the bottom of the figure indicate the observed change in miRNA expression in H1 and NT2 cells, following induction of differentiation [10].
b Graphical representation of selected primary transcripts of miR clusters, with the relative position of the pre-mirs and of the mature miRs. Mature
miRs are represented as colored boxes in the 5′ (-5p miR) or 3′ (-3p miR) side of the corresponding pre-mir. Each miR family is represented with a
distinct color. Families were defined, as represented in the TargetScan 7 database. For simplicity, only the first representative miR of the family was
used in the figure legend. Additional information regarding families can be found in Table S1 (in Additional file 2). Boxes with dotted lines indicate
miRs that were not evaluated in our study
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cytoplasm were found to be highly correlated features,
with distinct miRs eliciting similar effects on the levels
of both markers (Figs. 3 and 4 and Additional file 3:
Figures S4 and S5). This corroborates the assumption
that (at least for these microRNAs and cell lines)
changes in OCT4 and CCNB1 levels are able to indicate
if a given microRNA acts as a pro-pluripotency or pro-
differentiation factor.
As can be seen in the clustering results obtained for
NT2 cells (Fig. 3) and H1 cells (Fig. 4), the miRs were
divided into two major clusters: a cluster containing
miRs with pro-differentiation effects (i.e., reducing
OCT4 and CCNB1 levels), identified as cluster “A” for
both cell lines, and a cluster with pro-pluripotency miRs
(i.e., increasing OCT4 and CCNB1 levels), identified as
cluster “B” in NT2 cells, and as clusters “B” and “C” in
H1 hESCs.
Among miRs enriched in pluripotent cells and down-
regulated upon differentiation [10], miRs from families
miR-17-5p/20-5p/93-5p/106-5p/519-3p/526-3p (specific-
ally, miR-106a-5p from mir-106a~363 cluster) and miR-
302-3p/372-3p/373-3p/520-3p (specifically, miR-302a/b/
c/d-3p from mir-302b~367 cluster, and miR-372-3p and
miR-373-3p from mir-371a~373 cluster), which share
very similar seed sequences (AAAGUGC and AAGU
GCU, respectively), elicited similar phenotypic effects in
both cell lines, markedly increasing nuclear and cyto-
plasmic OCT4 and CCNB1 levels (clearly indicating a
pro-pluripotency effect). Similarly, miR-92-3p and 363-3p,
which belong to family miR-25-3p/32-5p/92-3p/363-3p/
367-3p (seed AUUGCAC) and originate from the mir-
106a~363 cluster (or, also, mir-17~92a-1, in the case of
miR-92-3p), also increased OCT4 and CCNB1 levels in
both cell lines.
On the other hand, among miRs upregulated upon dif-
ferentiation of H1 and/or NT2 cells [10], miR-29a/b-3p,
from mir-29b-1~29a cluster, induced a marked reduc-
tion in OCT4 and CCNB1 levels in both cell lines, as
also did miR-30a-5p (Fig. 2).
Importantly, despite large similarities between both
cell lines, some differences were clearly observed. For in-
stance, miRs 23a-3p, 27a-3p, and 24-2-3p, from mir-
23a~24-2 cluster, only reduced OCT4 and CCNB1 levels
in NT2 cells (Figs. 2 and 3), while in H1 this was only
evident for miR27a-3p (Figs. 2 and 4). Worth of notice,
miRs from this cluster were not induced upon differenti-
ation of NT2 cells (Fig. 2).
One of the most striking differences between the cell
lines was the effect elicited by miR-19ab-3p (miR19-3p
family) and miR-20ab-5p (also from family miR-17-5p/
20-5p/93-5p/106-5p/519-3p/526-3p), deriving from the
paralog clusters mir-17~92a-1 and mir-106a~363 (Fig. 2).
Despite being repressed upon differentiation of both cell
lines, these miRs markedly reduced OCT4 and CCNB1
levels in NT2 EC cells, but had the opposite effect in H1
hESCs. This result specifically highlights how miR-20-5p
Fig. 3 Clustering of miR-induced multiparametric phenotypic profiles in NT2 cells. NT2 cells were transfected with miR mimics and the negative
control miR-Ctr (PMC) and then submitted to quantitative fluorescence microscopy. Multiparametric phenotypic profiles specific for each miR
were submitted to hierarchical clustering analysis (centered correlation and average linkage). The resulting dendograms above or to the left of the
heatmap indicate, respectively, the similarities between the phenotypes induced by miRs (potentially reflecting shared targets and mechanisms of
action) or the correlation between distinct phenotypic features. The measurements depicted in the heatmap were calculated as percentage of control
(POC) (PMC in black). Highest POC values above or below the control are represented in bright yellow or blue, respectively
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and miR-106-5p have different effects, despite belonging
to the same family. Another unexpected finding was the
observed effect of miR-145-5p, miR-181d-5p, and miR-
222-3p, which despite being induced upon differenti-
ation of H1 hESCs [10] caused an increase in OCT4 and
CCNB1 levels in both cell lines.
Although the two main miR groups, resulting from the
hierarchical cluster analysis in both cell lines, successfully
separated pro-pluripotency from pro-differentiation
miRs, in H1 hESCs, miR-29a/b was grouped with pro-
pluripotency miRs in cluster B (instead of cluster A), as a
result of its effects on cell morphology and, more import-
antly, as a result from a marked reduction in cell counts.
Interestingly, this group included miR-18a/b-5p, miR-101-
3p, and miR-363-3p (all with similar effects in NT2 cells),
as well as miR-24-3p. Worth noticing, miR-92a-3p (from
the same family as miR-363-3p) did not reduce cell counts
in neither of the cell lines. Moreover, while both miRs in-
creased cell size in H1 hESCs, in NT2 cells, they reduced.
These findings demonstrate that the cell context largely
affects the net phenotypic effect of miRs, even from the
same family.
Identification of pathways targeted by clustered miRs
Given that miRs can have similar phenotypic effects by
targeting common components of a given signaling
pathway (or biological process) or, alternatively, by
targeting distinct components of the same pathway or
process [52, 53], we identified the predicted mRNA tar-
gets of each miRNA, using TargetScan Human 7.1 [48]
and selected transcripts commonly targeted by miRs
belonging to the same cluster. Finally, we used the
Database for Annotation, Visualization and Integrated
Discovery (DAVID) [49, 50] to identify signaling path-
ways and biological processes enriched for the set of
shared targets (see Additional file 4, an Excel file with all
results from the pathway analyses), which potentially
correspond to the most relevant pathways (Fig. 1, bot-
tom left panel).
We next compared the pathways identified for each of
the three phenotypic clusters with pro-pluripotency
characteristics in NT2 cells. From 102 potentially regu-
lated pathways, 45.1% were exclusive for subcluster B.1,
7.8% for subcluster B.2a, and 19.6% for subcluster B.2b
(top left Venn diagram in Fig. 5). On the other hand,
from 148 pathways identified for the pro-pluripotency
clusters in H1 hESCs, 10.1% were exclusive for subclus-
ter B.1, 17.6% for subcluster C.1, and 22.3% for subclus-
ter C.2 (top right Venn diagram in Fig. 5). Interestingly,
some pathways were shared by all clusters, like FoxO,
mTOR, and DICER pathways. A similar analysis was car-
ried for the pathways identified for the pro-differentiation
clusters in both cell lines (see Additional file 5, an Excel
file with all pathway comparisons).
Next, we compared all the pathways identified for pro-
pluripotency and pro-differentiation clusters in both cell
Fig. 4 Clustering of miR-induced multiparametric phenotypic profiles in H1 hESCs. H1 hESCs were transfected with miR mimics and the negative
control miR-Ctr (PMC) and then submitted to quantitative fluorescence microscopy. Multiparametric phenotypic profiles specific for each miR
were submitted to hierarchical clustering analysis (centered correlation and average linkage). The resulting dendograms above or to the left of the
heatmap indicate, respectively, the similarities between the phenotypes induced by miRs (potentially reflecting shared targets and mechanisms of
action) or the correlation between distinct phenotypic features. The measurements depicted in the heatmap were calculated as percentage of control
(POC) (PMC in black). Highest POC values above or below the control are represented in bright yellow or blue, respectively
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lines (bottom Venn diagram in Fig. 5). Interestingly,
among pathways exclusively enriched for targets of pro-
pluripotency-related miRs, we found one describing
“Presenilin action in Notch and Wnt signaling.” Import-
antly, this pathway was among the pathways exclusively
enriched for miR-targets of B.1 clusters, in NT2 and H1
hESCs, which corresponded to pluripotency-related miRs
with the distinguishing feature of restricting proliferation.
miR effects on predicted target transcript levels
Given that mammalian microRNAs predominantly act
to decrease target mRNA levels [6], in order to evaluate
the potential regulation of some predicted targets by
selected miRs, we transfected NT2 cells with miR
mimics or a control miR and then carried quantitative
PCR. From 10 predicted targets of miR-29b-3p (from
clusters A.3 and B.2 in NT2 and H1, respectively), a
statistically significant decrease (P < 0.05), as compared
to controls, was only observed for KLF4 and APC.
However, a noticeable decrease was also observed for
STAT3, IL2RA, FGFR1, and TGFB3 transcripts, whereas
CDKN2B were significantly increased, unexpectedly
(Fig. 6a). The other representative miRs and correspond-
ing phenotypic clusters in both cells (NT2/H1) were
miR-18b-5p (B.1/B.1), miR-20a-5p (A1/C1), miR-23a-3p
(A.2/C1), miR-24-3p (A.2/B.1), miR-30a-5p (A.2/A),
Fig. 5 Comparison of identified miR-regulated pathways in NT2 and H1. Predicted targets were identified using TargetScan, and those shared by
clustered miRs were submitted to an enrichment analysis using the DAVID tool, allowing the identification of pathways and processes potentially
regulated by these miRs at the post-transcriptional level. Top Venn diagrams: comparison of the identified pathways for all pro-pluripotency
clusters in NT2 (upper-left) and H1 (upper-right) cells. Bottom Venn diagram: comparison of all the pathways identified for pro-pluripotency (Pluri.
NT2 and Pluri. H1) and pro-differentiation clusters (Diff. NT2 and Diff. H1) in both cell lines. Venn diagrams were generated using Venny 3.0
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miR-92a-3p (B.2a/C.2c), miR-181d-5p (B.2b/C.1), miR-
222-3p (B.1/C.2b), miR-302a-3p (B.2a/C.2b), miR-363-3p
(B.1/B.1), miR-371a-3p (B.2b/C.2c), and miR-373-3p
(B.2b/C.2a). It is possible to observe that some miRs
caused statistically significant reductions in the levels of
their target mRNA transcripts (Fig. 6b). For instance,
miR-181d-5p reduced the levels of PTEN and MAPK1,
miR-20a-5p of FGF2 and TGFBR2, miR-24-3p of TCF3
and GSK3B, miR-30a-5p of MAPK1, and miR-222-3p
and miR-373-3p of TGFBR2.
miR-363-3p regulates Notch signaling pathway and
promotes pluripotency features
The identification of the pathway describing “Presenilin
action in Notch and Wnt signaling” as exclusively
enriched with predicted targets from pluripotency-related
Fig. 6 Effects of selected miRs on predicted target levels. NT2 cells were transfected with miR mimics or negative control (PMC), and mRNA levels
of predicted targets were evaluated by qPCR after 48 h. a Predicted target transcripts for miR-29a/b-3p. b Predicted target transcripts from representative
miRNAs from identified clusters. Mean expression level of PMC transfected cells were used as reference for the calculation of the relative expression,
using the 2^-DDCT method. *p< 0.05 (one-tailed non-parametric Mann-Whitney test)
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miRs, characteristically restricting the proliferation of
NT2 and H1 cells, attracted our attention, and we focused
further studies on this pathway.
In order to investigate the potential post-transcriptional
regulation of the Notch pathway, we compiled a list of all
Notch pathway components using the KEGG database
and used TargetScan to find which components were pre-
dicted targets of the evaluated miRs (see Additional file 2:
Table S4). Next, we selected distinct miRs to functionally
test their ability to counteract the differentiation induced
by Notch activation. To that end, we transfected NT2 cells
with pre-miR negative control (PMC) and co-cultured
them with murine OP9-DL1 stromal cells, expressing the
Notch activating ligand Delta-Like 1 (DL1) in their
surface, or with control OP9 stromal cells (OP9-Ctrl).
Additionally, NT2 cells were transfected with selected
miRs and co-cultured with OP9-DL1 cells.
In addition to miR-101-3p and miR-363-3p (pluripo-
tency-related miRs from the B.1 cluster characteristically
restricting proliferation in NT2 and H1 hESCs), we se-
lected additional miRs to be used as references, specific-
ally four miRNAs with more than ten targets in the
Notch pathway (miR-302c-3p, miR-101-3p, miR-363-3p,
and miR-92a-3p) and two miRs with less than five
targets (miR-222-3p and miR-371-3p). A statistically sig-
nificant reduction in OCT4 nuclear median intensity (ap-
proximately 20%) was observed in NT2 cells co-cultured
with OP9-DL1 cells, as compared to those co-cultured
with OP9-Ctrl cells, indicating that Notch signaling in-
duced differentiation (Fig. 7a). Additionally, when compar-
ing the effects of the evaluated miRs in the context of
Notch signaling, only miR-363-3p was able to counteract
Notch-induced differentiation (i.e., sustain nuclear OCT4
levels comparable to cells co-cultured with OP9-Ctrl
cells), as indicated by statistically significant higher nuclear
Oct4 levels, as compared to cells transfected with PMC
(Fig. 7a). Of notice, of the tested miRs, only miR-92a-3p,
miR-101-3p, and miR-363-3p targeted both NOTCH1 and
PSEN1, whereas miR-222-3p and miR-302c-3p targeted
only PSEN1. Of these, we found that miR-363-3p caused a
reduction in NOTCH1 and PSEN1 transcript levels,
suggesting a miR-induced degradation (Fig. 7b). Given these
data, we suggest that miR-363-3p induces pluripotency-
related characteristics by repressing Notch pathway activa-
tion via degradation of NOTCH1 and PSEN1 mRNA
transcripts.
Discussion
We present the first focused miR functional high-
content screen carried in human pluripotent cells. By
identifying targets shared by miRs causing similar multi-
parametric phenotypic profiles, we were able to pinpoint
post-transcriptionally regulated signaling pathways in-
volved in pluripotency and differentiation. In particular,
we show that the pluripotency-related microRNA miR-
363-3p targets NOTCH1 and PSEN1 inhibit differenti-
ation mediated by Notch signaling. Moreover, by
comparing NT2 cells to H1 hESCs, we show how
extremely contrasting effects can result from closely re-
lated miRs in the same cell or from the same miR in dif-
ferent cells.
Similarities and differences between hESCs and NTera-2
cells
Despite overall similarities, some miRs elicited contrast-
ing effects depending on the cellular context. For ex-
ample, OCT4 and CCNB1 levels were strongly repressed
by miR-19a/b-3p and miR-20a/b-5p in NT2 cells, but
were robustly induced in H1 cells. In turn, miR-92a-3p
and miR-363-3p had opposing effects on cell size, de-
creasing it in NT2 cells, while increasing it in H1 hESCs.
Conversely, some closely related miR (members of the
same family) had opposing effects in the same cell
line, despite identical seeds. For instance, miR-20a/b-5p
and miR-106a-5p showed pro-differentiation and pro-
pluripotency effects in NT2 cells, respectively. In turn,
miR-92-3p and miR-363-3p had opposite effects on prolif-
eration and nucleus size in the same cellular context, in
both cell lines.
Functional microRNA screening based on DGCR8 KO
mESCs shows contrasting phenotypic effect to human
pluripotent cells
In order to identify functional differences between the
tested miRs in human and mouse cells, we compared
our results with those observed in previously published
screenings using DGCR8 knockout mESCs [20–22]. The
first mESC screening consisted of a MTTassay to specific-
ally search for miRs able to recover the proliferation defect
of these cells [20]. From 266 mouse miRs screened, Wang
et al. identified members of the miR-290 family (including
miR-291a-3p, miR-294, and miR-295) promoting G1 to S
phase transition, naming them ES cell–specific cell cycle–
regulating (ESCC) miRs. All ESCC miRs belong to the
mir-290–295 cluster, homolog to the cluster miR-371-373
in human [54]. Moreover, miRs in this cluster contain
seed sequences similar or identical to miRs in the mir-302
and mir-17-92 clusters (AAAGUGC for family miR-17-
5p/20-5p/93-5p/106-5p/519-3p/526-3p and AAGUGCU
for family miR-302-3p/372-3p/373-3p/520-3p), which also
predominate in hESC [55].
Importantly, we found that miR-106a-5p, miR-302a/b/
c/d-3p, miR-372-3p, and miR-373-3p had the same ef-
fect in H1 hESCs and NT2 cells: increasing proliferation
(i.e., cell counts), cell size (i.e., area and perimeter), and
expression of OCT4 and CCNB1 in nucleus and cyto-
plasm (i.e., median intensity) and reducing nucleus size.
Of notice, increases in cell size and reduction in nucleus
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size were unanticipated effects captured only as a result
of our multiparametric high-content screen.
In mice, the miR-290~295 cluster is broadly expressed
throughout the embryo, but diminishes a few days
following implantation, remaining highly expressed in
extraembryonic tissues, in line with its roles in implant-
ation and placenta development [56, 57]. In contrast,
miR-302a-d cluster is expressed in the embryo proper
only after implantation [58, 59]. While deletion of miR-
302a-d particularly affects neural development, deletion
of miR-290 and miR-302a-d clusters results in early em-
bryonic lethality, revealing redundant functions during
early development [60].
Also using DGCR8 KO mESCs, Ma et al. evaluated
the effects of 40 microRNAs expressed at higher levels
in MEFs and EBs (as compared to mESC) and predicted
to target pluripotency-associated transcription factors,
including Oct4, Sox2, Nanog, Klf4, c-Myc, Lin28a, Sall4,
Rex1, and Stella [21]. Many miRs evaluated in our study
were also evaluated by Ma et al., in terms of their effects
on Oct4 staining, though not in a quantitative way. Of
all 40 miRs, 20 decreased Oct4 staining (including miR-
24-3p, 27a-3p, 92a-3p, and 29a-3p), 12 mildly decreased
Oct4 levels (including miR-23a-3p), and 8 miRs increased
Oct4 intensity (including miR-18a-5p and 30a-5p). Of no-
tice, we observed similar effects on Oct4 nuclear median
intensity (in both human cell lines) only for miR-23a-3p,
miR-24-3p, 27a-3p, and miR-29a-3p, which decreased
Oct4 levels in our screenings. Opposite results were found
for miR-92a-3p, which increased Oct4 levels in our
screening, and for miR-18a-5p and miR-30a-5p, which re-
pressed Oct4 levels. Nevertheless, our results regarding
Fig. 7 miR-363-3p targets NOTCH1 and PSEN1 and inhibits Notch-induced differentiation in NT2 cells. a NT2 cells were transfected with miR
mimic and negative control (PMC), and 72 h later, they were co-cultured with OP9-Ctrl or OP9-DL1 stromal cells for more 24 h. Nuclear OCT4
median intensity was then quantified by automated quantitative fluorescence microscopy. Kruskal-Wallis test followed with Dunn’s multiple
comparison test. b NT2 cells were transfected with miR-363-3p mimics and PMC and NOTCH1, and PSEN1 transcript levels were evaluated 48 h
later by qPCR. Mean expression level of PMC transfected cells were used as reference for the calculation of the relative expression, using the
2^-DDCT method. *p < 0.05 (one-tailed non-parametric Mann-Whitney test)
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miR-92a-3p and miR-30a-5p were in line with their ex-
pected roles based on the expression behavior in differen-
tiating hESCs [10].
On the other hand, when evaluating mESC colony-
forming ability, 17 miRs decreased it (including miR-24-
3p, miR-27a-3p, miR-29b-3p), 15 did not affect it
(including miR-29a-3p, miR-27b-3p, miR-92a-3p, miR-
145a-5p, miR-18a-5p, and miR-30a-5p), and 8 enhanced
it (including miR-23a-3p and 23b-3p). Since colony-
forming ability derives, in part, from the proliferation
and survival of plated cells, we compared it to the miR
effects on cell counts obtained by us. In H1 hESCs, we
found that miR-24-3p and miR-29a/b-3p decreased cell
counts (in line with lower colony numbers), while miR-
27a-3p increased cell counts (in contrast to decreased
colony numbers). In line with higher colony numbers,
miR-23a-3p also increased cell counts in H1 hESCs and
NT2 cells. In contrast to the decreased colony formation
ability observed by Ma et al., we found that miR-24-3p,
miR-27a-3p, and miR-29b-3p increased cell counts in
NT2 cells. These contrasts between DGCR8 KO mESCs
and H1 hESCs may derive from differences related to
the absence of endogenous miRs, but also from differ-
ences regarding the pluripotency state of mouse and hu-
man ESCs (naïve vs primed, respectively). Importantly,
according to Ma et al., miR-27a and miR-24 would exert
their pro-differentiation effects, in part, by directly tar-
geting the pluripotency-associated factors Oct4 and
Foxo1 and the signal transducers gp130 and Smads [21].
Given our findings, it is likely that the above mechanism
may not completely apply to hESCs.
As mentioned before, many miRs able to downregulate
AP activity on Dgcr8 knockout mESCs cannot do so on
wild-type cells [61]. Additionally, DGCR8 also acts in the
maturation of snoRNAs and in the degradation of tel-
omerase RNA [62]. Finally, in the absence of endogenous
miRs, the RNAi machinery of DGCR8 KO cells becomes
completely available to the exogenously introduced miR,
likely resulting in an enhanced effect (including off-target
effects of siRNAs). Altogether, our results further stress
important differences that compromise a straightforward
comparison and translation of the findings obtained with
DGCR8 KO mESCs to those obtained with wild-type
ESCs, further highlighting the importance of our study.
For further discussions, the reader can refer to our review
comparing all arrayed genetic screens (siRNAs and micro-
RNAs) carried in the context of pluripotency, reprogram-
ming, and differentiation, published up to date [18].
microRNAs in naïve and primed pluripotency
In a more recent work, Gu et al. used DGCR8 KO
mESCs to evaluate the transition from mESCs in a naive
state of pluripotency to epiblast-like cells (EpiLCs) in a
primed state. The authors identified 50 upregulated
miRs, including those of the miR-302 cluster, while other
miRs with similar seeds, such as miR-290 cluster and
miR-17-20-106 families, were not altered. By using qRT-
PCR, Gu et al. found that miRs from the miR-302 clus-
ter strikingly repressed the expression of naive markers
(Rex1 and Klf2) and induced the post-implantation epi-
blast marker Fgf5; nevertheless, those from the miR-290
cluster also facilitated the exit from naive pluripotency
[22]. The role of miR-302 cluster miRs in the transition
to the primed state would be in line with its expression
following implantation [58, 59]. Moreover, two studies
identified microRNAs expressed at higher levels in naive
cells of mice or humans (including those from the miR-
371-373 cluster in human, or miR-290~295 in mice), as
well as those expressed at higher levels in primed cells
(miR-302 family and miR-363) [63, 64].
Naïve mESCs, derived from the inner cell mass (ICM)
from pre-implantation blastocyst [65], and primed
EpiSCs, derived from the implanted blastula epiblast [66,
67], differ in many characteristics. Human ESCs, which
are derived from blastocysts from in vitro fertilization,
are considered to be more similar to mouse EpiSCs [68].
All miRs from the miR-302-3p family evaluated by us
(miR-302a/b/c/d-3p, miR-372-3p, and miR-373-3p)
showed conserved functional roles in NT2 and H1
hESCs, increasing proliferation, expression of OCT4/
CCNB1, and cell size (and also reducing nucleus size).
Based on these results and given that the miRs enriched
in both pluripotency states share similar seeds, it is evident
that miRs from the same or related families (but belonging
to clusters transcriptionally regulated in an independent
manner during development) can have pluripotency-
related roles in both naive and primed cells. Moreover, they
may likely contribute bi-directionally during naive-primed
interconversion, depending on the experimental setting, as
exemplified by miRs from the miR-302 and miR-290 clus-
ters facilitating the exit from naive pluripotency [22]. How-
ever, given that DGCR8 KO mESC fails to completely
silence the naive program and to establish the primed one,
it remains to be shown if these findings translate to wild
mESCs or hESCs.
Context-dependent effects of microRNAs on pluripotency
and reprogramming
While the pro-pluripotency roles of miR-302 and miR-294
were expected, since they are enriched in pluripotent cells
and are repressed during differentiation, the pro-
pluripotency role of miR-181 family members is more in-
triguing. While Stadler et al. [10] found these miRs to be
induced during differentiation of hESCs (miR-181b and d)
and NT2 cells (miR-181a and b), we found that miR-
181d-5p considerably increased OCT4 nuclear levels and
cell counts, also reducing cell and nucleus size, in both
our screenings. Importantly, ESCC miR mimics from
de Souza Lima et al. Stem Cell Research & Therapy          (2019) 10:202 Page 13 of 18
miR-302 and miR-290 clusters and from the miR-181 fam-
ily all promote the initiation phase during OSK-mediated
reprogramming of MEFs into iPSCs [69–71], in line with
their pro-pluripotency roles. In mESCs, miR-181 family
members are transcribed from three distinct clusters, dif-
ferentially bound by Oct4, Sox2, Nanog, and TCF3 TFs,
and expressed in pluripotent and differentiated cells.
While miR-181a-1~181b-2 cluster is bound by all these
TFs and expressed in neural precursors and MEFs, miR-
181c~181d cluster is bound by all TFs except TCF3 and is
expressed only in mESCs; finally, cluster miR-181a-
2~181b-1 (in chr1) is expressed only in neural precursors
and is not bound by any of these TFs [24]. Interestingly,
the differential regulation of these clusters by TCF3 during
reprogramming could be implicated in the stage-specific
regulation of reprogramming by Tcf3, promoting it in the
early phase, while inhibiting in the later stages [72].
MiRs from the miR-181 family are also induced during
mESC differentiation, targeting Cbx7, the primary Poly-
comb ortholog of Polycomb repressive complexes 1
(PRC1) which reads repressive H3K27me3 histone marks
left by PRC2, leading to derepression of bivalent genes en-
coding lineage-specific TFs and markers [2, 73–75]. In
contrast, ectopic expression of Cbx7 in mESC enhances
self-renewal and inhibits differentiation and X chromo-
some inactivation; in turn, upon its knockdown, mESC
colonies display a flattened morphology [73], characteris-
tics related to the naïve or primed states, respectively.
Thus, similar to the miR-302 family, although miR-181
family possesses pluripotency-related properties, it may be
associated with the transition to the primed state, by tar-
geting Cbx7.
In addition to miR-181d-5p, miR-145-5p and miR-
222-3p were also induced in pluripotent cells upon
differentiation [10] and similarly found to considerably
enhance OCT4 nuclear levels in both our screenings (in-
creasing cell counts and reducing cell and nucleus sizes).
For miR-145-5p, our results were particularly unex-
pected, as this miR was shown to target OCT4, SOX2,
and KLF4, negatively regulating their translation during
cell differentiation [76]. Moreover, the inhibition of this
miR during reprogramming was shown to increase the
efficiency of iPSC generation [77]. These conflicting
findings may result from differences between the transi-
ent effect mediated by transfection of mimics, as com-
pared to the sustained and strong expression mediated
by lentiviral vectors. In fact, contrasting findings arising
from different methods used were previously pointed
out by our group in the study of the miR-29 family.
Using transfection of synthetic miRs or inhibitors, our
group and others showed that miR-29a hampers repro-
gramming by different mechanisms, including activation
of WNT/beta-catenin signaling (by targeting GSK3B)
and targeting of active DNA demethylation enzymes of
the TET family [71, 78, 79]. Strikingly in contrast, expres-
sion of miR-29 throughout the process using a retroviral
vector promotes reprogramming, an effect resulting from
passive global demethylation following constitutive knock-
down of the targets Dnmt3a and Dnmt3b [80]. However,
transient reduction of DNMT3a/b by siRNAs does not
affect reprogramming [81].
Many effects of miRs (such as ESCC miRs) on pluripo-
tency and reprogramming have been attributed to their
function in the regulation of key cell cycle regulators
[20, 61, 82–84]. In fact, while induction of cell pro-
liferation increases reprogramming efficiency, cell-cycle
arrest inhibits it [85]. Thus, many miRs physiologically
associated with differentiation of ESCs may promote
reprogramming and pluripotency in vitro, trough cell
cycle-mediated effects.
miR-363-3p sustains pluripotency by repressing Notch-
induced differentiation
By comparing all the pathways enriched for predicted
targets of the pro-pluripotency clusters to those of the
pro-differentiation clusters, we noticed that a pathway
describing “Presenilin action in Notch and Wnt signal-
ing” was exclusively associated with pluripotency-related
clusters, more specifically with those that characteristic-
ally restricted proliferation in NT2 and H1 hESCs. This
prompted us to explore the potential role of Notch sig-
naling in pluripotency and more specifically to evaluate
the potential role of selected miRs in the inhibition of
Notch signaling.
In general, Notch signaling begins with the interaction
of surface-bound ligands (such as Delta or Jagged) with
transmembrane Notch receptors (NOTCH1 to 4), lead-
ing to its cleavage (by a gamma-secretase complex con-
taining presenilin, PSEN1) and release of the Notch
intracellular domain (NICD), which translocates to the
nucleus and forms a complex with the protein RBP-Jk
(CSL). This complex binds to DNA cis-regulatory ele-
ments along with coactivators proteins (including p300
and proteins of the MAML family), activating the tran-
scription of its target genes [86]. As shown by us, Notch
signaling (mediated by OP9-DL1 cells) induced differen-
tiation of co-cultured NT2 cells. Moreover, miR-363-3p
was able to counteract Notch-induced differentiation,
also reducing the transcript levels of its predicted targets
PSEN1 and NOTCH1, central players in Notch signal-
ing, in line with the previously reported direct targeting
of NOTCH1 by miR-363-3p [87, 88].
Components of the NOTCH pathway are expressed
both in hESCs and in NTERA2 cells [89]. Although ini-
tial studies concluded that Notch would positively regu-
late the proliferation of hESCs [90, 91], later studies
revealed that this conclusion was likely derived from the
unspecific cytotoxic effect of the Notch inhibitor used in
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these studies, including DAPT [91] and L685458 [90]
and, also, by the unspecific activation of Notch by
Tripsin/EDTA passaging during culture [92]. In fact,
although the Notch pathway is inducible in hESCs, it re-
mains inactive and is not necessary for the propagation
of undifferentiated cells, but instead is required for the
maintenance of differentiating cells that accumulate in
culture [92]. The pro-differentiation role of Notch in
hESCs was corroborated in a study showing that Notch
signaling inhibition by GSI-18 maintained cells undiffer-
entiated, preventing spontaneous differentiation to all
three germ layers, while allowing trophoblastic differen-
tiation [93]. Interestingly, Oct4 physically interacts with
RBP-Jk in mESC [94], and siRNA knockdown of OCT4
in H1 hESCs induces the transcription of Notch pathway
components and targets, including NOTCH2, TLE2,
DTX4, and HES1 [95], suggesting a connection between
Notch and Oct4-regulated gene expression.
Interestingly, Annab et al. identified two coexisting
subpopulations in hESC, one composed of rounder cells
expressing higher levels of Nanog and KLF4 and a more
heterogeneous population expressing high levels of
Notch components, including NOTCH1, NOTCH2,
JAG1, DLL1, HES1, and DTX1 [96]. Given that hESCs
chemically reverted to the naive pluripotency state ex-
press higher levels of Nanog and KLF4 [97], this could
indicate that the expression of Notch components could
be associated with a primed population of hESCs. Strik-
ingly, a recent study in search of surface markers capable
to distinguish naive and primed states of hESC identified
NOTCH receptors 1 and 2 as being specifically
expressed in the primed state, while the LIF coreceptor
(GP130/IL6ST) was detected exclusively in naive-state
hESCs [98].
Importantly, a mechanism involving the oscillatory ac-
tivation of Notch (mediated by the inhibition of Notch
signaling by its transcriptional target HES1) would con-
tribute to the heterogeneous differentiation responses
displayed by ESCs. Specifically, cells expressing low or
high levels of Hes1 (i.e., with active or inactive Notch
signaling, respectively) differentiate preferentially into
neural or mesodermal cells, respectively [99–101].
Altogether, this would indicate that expression of
Notch components in ESCs would be associated with
primed cells displaying a more prone and heterogeneous
potential to differentiation, what would be linked to the
oscillatory activity of the Notch-Hes1 axis. In turn, the
absence of Notch components would be associated with
a more homogeneous cell population of naïve cells ex-
pressing higher levels of pluripotency factors and with
the potential to give rise to the trophectoderm. Up to
date, the function of the Notch pathway in the context
of the transition between naive and primed states has
not been investigated in the literature. However, a
recently deposited patent (WO2014174470), defining
conditions (referred to as WIS-NHSM) for naive cell
generation [102], suggests that Notch inhibitors could
contribute to the consolidation of the naive pluripotency
state of ESCs [103]. We are currently undertaking this
investigation. Thus, although miR-363 is enriched in
primed cells [63, 64], inhibition of the Notch pathway
may likely be a general mechanism for the maintenance
of pluripotency in both naive and primed ESCs.
Conclusions
By using automated quantitative fluorescence microscopy
(i.e., high-content screening) to evaluate the phenotypic ef-
fects of microRNA mimics transfected into pluripotent cell
lines and by identifying transcripts commonly targeted by
microRNAs inducing similar multiparametric phenotypic
profiles (as revealed by hierarchical clustering and in-silico
target prediction), we were able to identify signaling path-
ways and biological processes post-transcriptionally modu-
lated by distinct microRNA groups. Integration of this type
of data with similar data obtained from siRNA screenings
(using the same HCS assay) could provide a large-scale
functional approach to identify and validate microRNA-
mediated regulatory mechanisms controlling pluripotency
and differentiation.
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